Mankind Pharma Ltd Quarterly Results: Standalone & Consolidated Reports

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Cr

Consolidate Quarterly Results

Jun'26

Mar'26

Dec'25

Sep'25

Jun'25

Mar'25

Dec'24

Net Sales

4,030.59

3,442.93

3,567.20

3,697.16

3,570.35

3,079.37

3,198.79

Other Operating Income

0.00

Total Operating income

4,030.59

3,442.93

3,567.20

3,697.16

3,570.35

3,079.37

3,198.79

Raw Material Cost

684.85

554.95

553.04

594.36

585.68

554.25

532.40

Purchase of Finished goods

547.28

498.36

411.67

412.97

404.97

411.12

387.30

(Increase) / Decrease In Stocks

-133.86

-94.94

13.28

54.84

62.94

-89.99

11.81

Employee Cost

913.50

751.60

823.71

825.18

783.41

715.80

704.75

Power Cost

0.00

Manufacturing Expenses

0.00

Selling and Distribution Expenses

0.00

Other Expenses

962.63

803.08

846.07

888.48

886.58

805.00

746.54

Total Expenditure (Excl Depreciation)

2,974.40

2,513.05

2,647.77

2,775.83

2,723.58

2,396.18

2,382.80

Operating Profit (PBDIT) excl Other Income

1,056.19

929.88

919.43

921.33

846.77

683.19

815.99

Other Income

45.00

114.29

72.75

91.87

79.88

251.33

77.00

Operating Profit (PBDIT)

1,101.19

1,044.17

992.18

1,013.20

926.65

934.52

892.99

Interest

109.98

141.75

157.20

169.68

170.65

190.54

220.93

Exceptional Items

0.00

-23.16

-106.59

0.00

-4.34

6.65

Gross Profit (PBDT)

991.21

879.26

728.39

843.52

756.00

743.98

672.06

Depreciation

225.70

223.08

222.60

221.82

218.68

230.87

187.17

Profit Before Tax

769.45

659.17

509.00

624.02

540.49

515.43

488.33

Tax

195.36

99.75

95.12

103.84

95.87

86.44

110.46

Provisions and contingencies

0.00

Profit After Tax

570.15

556.43

410.67

517.86

441.45

426.67

374.43

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

-4.34

6.65

Net Profit

570.15

556.43

410.67

517.86

441.45

422.33

381.08

Share in Profit of Associates

3.94

2.99

3.21

2.32

3.17

2.32

3.44

Minority Interest

6.03

5.07

5.13

8.67

6.30

3.88

4.29

Other related items

0.00

Consolidated Net Profit

568.06

554.35

408.75

511.51

438.32

420.77

380.23

Equity Capital

41.30

41.28

41.26

Face Value

1.0

Reserves

0.00

Earnings per share (EPS)

13.75

13.43

9.9

12.39

10.62

10.2

9.22

Diluted Earnings per share

13.74

13.41

9.89

12.38

10.6

10.18

9.44

Operating Profit Margin (Excl OI)

26.2%

27.01%

25.77%

24.92%

23.72%

22.19%

25.51%

Gross Profit Margin

24.59%

25.54%

20.42%

22.82%

21.17%

24.16%

21.01%

PAT Margin

14.24%

16.25%

11.6%

14.07%

12.45%

13.93%

11.81%

Public Share Holdings (%)

0.0%

Pledged Promotor Holding (%)

0.0%

Quarterly Analysis Highlights - QoQ

Net Sales

QoQ Growth in quarter ended Jun 2026 is 17.07% vs -3.48% in Mar 2026

Consolidate Net Profit

QoQ Growth in quarter ended Jun 2026 is 2.47% vs 35.62% in Mar 2026

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Jun 2026 is 13.58% vs 1.14% in Mar 2026

Interest

QoQ Growth in quarter ended Jun 2026 is -22.41% vs -9.83% in Mar 2026

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Jun 2026 has fallen from Mar 2026

Compare Quarterly Results Of Mankind Pharma With

Select Peers

Figures in Cr

Consolidate Quarterly Results

Change(INR)

Change(%)

Net Sales

4,030.59

7,587.00

-3,556.41

-46.88%

Other Operating Income

0.00

Total Operating income

4,030.59

7,587.00

-3,556.41

-46.88%

Raw Material Cost

684.85

1,347.20

-662.35

-49.16%

Purchase of Finished goods

547.28

971.70

-424.42

-43.68%

(Increase) / Decrease In Stocks

-133.86

-342.60

208.74

60.93%

Employee Cost

913.50

1,238.80

-325.30

-26.26%

Power Cost

0.00

Manufacturing Expenses

0.00

Selling and Distribution Expenses

0.00

Other Expenses

962.63

1,817.50

-854.87

-47.04%

Total Expenditure (Excl Depreciation)

2,974.40

5,032.60

-2,058.20

-40.90%

Operating Profit (PBDIT) excl Other Income

1,056.19

2,554.40

-1,498.21

-58.65%

Other Income

45.00

134.20

-89.20

-66.47%

Operating Profit (PBDIT)

1,101.19

2,688.60

-1,587.41

-59.04%

Interest

109.98

123.00

-13.02

-10.59%

Exceptional Items

0.00

-397.50

397.50

100.00%

Gross Profit (PBDT)

991.21

2,168.10

-1,176.89

-54.28%

Depreciation

225.70

508.40

-282.70

-55.61%

Profit Before Tax

769.45

1,659.70

-890.25

-53.64%

Tax

195.36

318.40

-123.04

-38.64%

Provisions and contingencies

0.00

Profit After Tax

570.15

1,341.30

-771.15

-57.49%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

570.15

1,341.30

-771.15

-57.49%

Share in Profit of Associates

3.94

-0.30

4.24

1,413.33%

Minority Interest

6.03

68.50

-62.47

-91.20%

Other related items

0.00

Consolidated Net Profit

568.06

1,272.50

-704.44

-55.36%

Equity Capital

41.30

100.60

-59.30

-58.95%

Face Value

1.00

0.00

Reserves

0.00

Earnings per share (EPS)

13.75

12.65

1.10

8.70%

Diluted Earnings per share

13.74

12.65

1.09

8.62%

Operating Profit Margin (Excl OI)

26.20%

34.36%

0.00

-8.16%

Gross Profit Margin

24.59%

29.16%

0.00

-4.57%

PAT Margin

14.24%

18.04%

0.00

-3.80%

Public Share Holdings (%)

0.00%

0.00

0.00%

Pledged Promotor Holding (%)

0.00%

0.00

0.00%

Quarterly - Net Sales

Net Sales 4,030.59 Cr

in Jun 2026

Figures in Cr

QoQ Growth in quarter ended Jun 2026 is 17.07% vs -3.48% in Mar 2026

YoY Growth in quarter ended Jun 2026 is 12.89% vs 24.50% in Jun 2025

Quarterly - Consolidate Net Profit

Consolidate Net Profit 568.06 Cr

in Jun 2026

Figures in Cr

QoQ Growth in quarter ended Jun 2026 is 2.47% vs 35.62% in Mar 2026

YoY Growth in quarter ended Jun 2026 is 29.60% vs -18.30% in Jun 2025

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 1,056.19 Cr

in Jun 2026

Figures in Cr

QoQ Growth in quarter ended Jun 2026 is 13.58% vs 1.14% in Mar 2026

YoY Growth in quarter ended Jun 2026 is 24.73% vs 26.09% in Jun 2025

Quarterly - Interest

Interest 109.98 Cr

in Jun 2026

Figures in Cr

QoQ Growth in quarter ended Jun 2026 is -22.41% vs -9.83% in Mar 2026

YoY Growth in quarter ended Jun 2026 is -35.55% vs 1,474.26% in Jun 2025

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 26.20%

in Jun 2026

Figures in %

QoQ Growth in quarter ended Jun 2026 has fallen from Mar 2026

YoY Growth in quarter ended Jun 2026 has improved from Jun 2025